Neurohormonal Activation does not explain Elevated Tissue Factor Expression in Heart Failure

Tien MH Ng; Kai I. Cheang; Mark A. Munger; Karleen S. Callahan

doi:10.1055/s-0037-1612967

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2002; 87(01): 176-177
DOI: 10.1055/s-0037-1612967

Letters to the Editor

Schattauer GmbH

Neurohormonal Activation does not explain Elevated Tissue Factor Expression in Heart Failure

Authors

Tien MH Ng

¹Departments of Pharmacy Practice and University of Utah Health Sciences Center, Salt Lake City, UT, USA
Kai I. Cheang

¹Departments of Pharmacy Practice and University of Utah Health Sciences Center, Salt Lake City, UT, USA
Mark A. Munger

¹Departments of Pharmacy Practice and University of Utah Health Sciences Center, Salt Lake City, UT, USA
Karleen S. Callahan

²Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, UT, USA

Abstract

Full Text

References

References
1 Osterud B. Tissue factor: a complex biological role. Thromb Haemost 1997; 78 (01) 755-7.
2 Kirchhofer D, Nemerson Y. Initiation of blood coagulation: the tissue factor/factor VIIa complex. Curr Opin Biotech 1996; 07: 386-91.
3 Rapaport SI, Roa LMV. Initiation and regulation of tissue factor-dependent blood coagulation. Arterioscler Thromb 1992; 02 (10) 1111-21.
4 Furniss SM, Munger MA, Gilbert EM, Stoddard GJ, Callahan KS. Monocyte tissue factor is elevated in heart failure. Circulation 1997; 96: 1-43.
5 Cheang KI, Munger MA, Kenney JK, Ng TMH, Gilbert EM, Callahan KS. Is monocyte tissue factor clinically significant in chronic heart failure?. J Card Fail 2000 (Suppl. 02) 06 (03) 222.
6 Cohn JN, Levine BT, Francis GS, Goldsmith S. Neurohormonal control mechanisms in congestive heart failure. Am Heart J 1981; 102: 509-14.
7 Katz SD, Biasucci L, Sabba C, Strom JA, Jondeau G, Galvao M, Soloman S, Nikolic SD, Forman R, Le Jemtel Ft. Impaired endothelium mediated vasodilation in peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 1992; 19: 918-25.
8 Zelis R, Davis D. The sympathetic nervous system in congestive heart failure. Heart Fail 1986; 02: 21-32.
9 Dzau VJ. Contributions of neuroendocrine and local autocrine-paracrine mechanisms to the pathophysiology and pharmacology of congestive heart failure. Am J Cardiol 1982; 62: 76E-81E.
10 Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819-25.
11 Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M, Probstfield JL, Yusuf S. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. Circulation 1996; 94: 690-7.
12 Boyum A. Isolation of human blood monocytes with Nycodenz, a new non-ionic iodinated gradient medium. Scand J Immunol 1983; 17: 429-36.
13 Terry CM, Callahan KC. Protein kinase C regulates cytokine-induced tissue factor transcription and procoagulant activity in human endothelial cells. J Clin Lab Med 1996; 127: 81-93.
14 Halim A, Kanayama N, Maradny EE, Maehara K, Terao T. Coagulation in vivo microcirculation and in vitro caused by endothelin-1. Thrombo Res 1993; 72: 203-9.
15 Drimal J, Mislovicova M, Ismail A, Moncek F. Detrimental subtype-specific endothelin-1 (ET-1) signaling in myocardial cells: the ET(A) mediated proliferation and ET(B) receptor down-regulation. Physio Res 1999; 48 (01) 9-19.
16 Zolk O, Quattek J, Sitzler G, Schrader T, Neikenig G, Schnabel P, Shimada K, Takahashi M, Bohm M. Expression of endothelin-1, endothelin-convert-ing enzyme, and endothelin receptors in chronic heart failure. Circulation 1999; 99 (16) 2118-23.
17 Kobayshi T, Miyauchi T, Sakai S, Maeda S, Yamaguchi I, Goto K, Sugishita Y. Down-regulation of ET(B) receptor, but not ET( A) receptor, in congestive lung secondary to heart failure. Are marked increases in circulating endothelin-1 partly attributable to decreases in lung ET(B) receptor-mediated clearance of endothelin-1? Life Sci 1998; 62 (02) 185-93.